Literature DB >> 17824157

Survey of utilization of medetomidine and atipamezole in private veterinary practice in Quebec in 2002.

M Johanna Kaartinen1, Sophie Cuvelliez, Line Brouillard, Yves Rondenay, Jean Jacques Kona-Boun, Eric Troncy.   

Abstract

This survey evaluates early perceptions about the use of medetomidine and atipamezole among veterinary practitioners in Quebec in 2002. Response rate was 23.5%; 71.1% of the practitioners did not use these products because of lack of information (69.3%), unavailability of the drugs in the practice (23.3%), or other reasons (7.3%), including concerns about the safety of alpha-2 agonists. Most veterinarians who used these products (70.4%) used them only rarely. Sedation by medetomidine was qualified as good (44.2%) or excellent (36%), and analgesia as good (46.5%) or average (32.7%). Waking up after atipamezole was qualified as good (47.5%) or excellent (40.9%). These perceptions indicate an opportunity for wider use of the products in veterinary practice. With more education and experience, practitioners could find medetomidine hydrochloride alone or in combination with an opioid useful for sedation, analgesia, and premedication for healthy animals. Reversal with atipamezole hydrochloride is considered effective, when residual sedation is undesirable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17824157      PMCID: PMC1899846     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  36 in total

1.  Survey of anesthesia techniques and concerns in private veterinary practice.

Authors:  A E Wagner; P W Hellyer
Journal:  J Am Vet Med Assoc       Date:  2000-12-01       Impact factor: 1.936

Review 2.  Clinical uses of alpha2 -adrenergic agonists.

Authors:  T Kamibayashi; M Maze
Journal:  Anesthesiology       Date:  2000-11       Impact factor: 7.892

Review 3.  Perioperative use of selective alpha-2 agonists and antagonists in small animals.

Authors:  Kip A Lemke
Journal:  Can Vet J       Date:  2004-06       Impact factor: 1.008

Review 4.  The clinical efficacy of medetomidine.

Authors:  T Vähä-Vahe
Journal:  Acta Vet Scand Suppl       Date:  1989

5.  Cardiovascular and pulmonary effects of a new sedative/analgesic (medetomidine) as a preanaesthetic drug in the dog.

Authors:  K Bergström
Journal:  Acta Vet Scand       Date:  1988       Impact factor: 1.695

6.  Sedative and analgesic effects of medetomidine in dogs.

Authors:  O Vainio; T Vähä-Vahe; L Palmu
Journal:  J Vet Pharmacol Ther       Date:  1989-06       Impact factor: 1.786

7.  Effects of xylazine and acetylpromazine upon induced ventricular fibrillation in dogs anesthetized with thiamylal and halothane.

Authors:  W W Muir; L L Werner; R L Hamlin
Journal:  Am J Vet Res       Date:  1975-09       Impact factor: 1.156

Review 8.  A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice.

Authors:  Melissa D Sinclair
Journal:  Can Vet J       Date:  2003-11       Impact factor: 1.008

9.  Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs.

Authors:  Wei-Chen Kuo; Robert D Keegan
Journal:  Am J Vet Res       Date:  2004-07       Impact factor: 1.156

10.  Alterations in epinephrine-induced arrhythmogenesis after xylazine and subsequent yohimbine administration in isoflurane-anesthetized dogs.

Authors:  W J Tranquilli; J C Thurmon; G J Benson
Journal:  Am J Vet Res       Date:  1988-07       Impact factor: 1.156

View more
  2 in total

1.  Effects of early atipamezole reversal of medetomidine-ketamine anesthesia in mice.

Authors:  Naomi J Baker; John C Schofield; Mark D Caswell; Alexander D McLellan
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-11       Impact factor: 1.232

2.  Effects of medetomidine on intra-renal arteries resistive and pulsatility indices in clinically normal adult domestic shorthair cats.

Authors:  Farzaneh Azizi; Mohammad Nasrollahzadeh Masouleh; Seeyamak Mashhadi Rafie; Ahmad Asghari; Saied Bokaie
Journal:  Vet Res Forum       Date:  2018-06-05       Impact factor: 1.054

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.